OS9 Antikörper (AA 466-667)

Produktnummer ABIN5014066

Produktdetails anti-OS9 Antikörper

Target: OS9 (Osteosarcoma Amplified 9, Endoplasmic Reticulum Lectin (OS9))

Bindungsspezifität: AA 466-667

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser OS9 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC)

Spezifität: The antibody is a rabbit polyclonal antibody raised against OS9. It has been selected for its ability to recognize OS9 in immunohistochemical staining and western blotting.

Aufreinigung: Antigen-specific affinity chromatography

Immunogen: OS9 (Asn466-Phe667)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

• Western blotting: 1:50-400 Immunocytochemistry in formalin fixed cells: 1:50-500 Immunohistochemistry in formalin fixed frozen section: 1:50-500 Immunohistochemistry in paraffin section: 1:10-100 Enzyme-linked Immunosorbent Assay: 1:100-1:5000 Optimal working dilutions must be determined by end user.

Kommentare:

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: Lot specific

Buffer: PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.

Details zu OS9

Target: OS9 (Osteosarcoma Amplified 9, Endoplasmic Reticulum Lectin (OS9))

Andere Bezeichnung: Osteosarcoma Amplified 9 (OS9) (OS9 Produkte)

Hintergrund: Alternative Names: ERLEC2, Amplified In Osteosarcoma, Endoplasmic Reticulum Lectin 2, Erlectin 2

Pathways: Maintenance of Protein Location, SARS-CoV-2 Protein Interaktom